MedTrace Logo

The Impact of Vaginal and IM Progestins on the Cervix

NCT01954095 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2015-12-02

No results posted yet for this study

Summary

The purpose of this study is to analyze how the body handles and responds to progesterone treatment in parous and nulliparous women at risk of pre-term birth.

Conditions

Sponsors & Collaborators

  • Indiana University

    collaborator OTHER

  • University of Texas

    collaborator OTHER

  • University of Washington

    collaborator OTHER

  • RTI International

    collaborator OTHER

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Mary F Hebert, PharmD, FCCP · University of Washington

  • Steve Caritis, MD · University of Pittsburgh

  • Gary Hankins, MD · University of Texas

  • David Flockhart, MD, PhD · Indiana University School of Medicine

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-01-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01954095 on ClinicalTrials.gov